US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.640
  • +0.010+0.13%
Close Aug 16 16:00 ET
  • 7.640
  • 0.0000.00%
Post 20:02 ET
1.58BMarket Cap-10465P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
-39.39%-32.44M
Net income from continuing operations
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
Operating gains losses
----
----
--29.02M
--0
--0
----
----
----
----
----
Depreciation and amortization
-21.38%320K
-24.44%306K
15.17%1.66M
6.82%423K
7.97%420K
21.49%407K
27.76%405K
84.94%1.44M
131.58%396K
69.87%389K
Other non cash items
-17.36%19.6M
-4.95%19.44M
-13.65%86.23M
-55.42%19.94M
20.22%22.11M
33.85%23.72M
7.63%20.45M
84.21%99.85M
151.81%44.73M
33.52%18.39M
Change In working capital
-175.38%-18.3M
-75.44%-48.52M
45.03%-32.4M
253.94%18.1M
9.64%-16.2M
-301.58%-6.64M
15.04%-27.66M
-825.57%-58.95M
-179.66%-11.76M
-311.17%-17.93M
-Change in receivables
8.25%-8.25M
-290.14%-3.84M
71.61%-6.1M
61.14%-2.97M
358.96%3.84M
-69.73%-8.99M
128.65%2.02M
-3.14%-21.47M
-136.04%-7.64M
-206.23%-1.48M
-Change in inventory
-17.71%739K
-1,031.30%-1.22M
88.33%-1.45M
178.19%907K
7.84%-3.39M
112.41%898K
137.01%131K
-41.70%-12.42M
45.72%-1.16M
3.85%-3.67M
-Change in prepaid assets
64.16%1.75M
143.42%1.11M
-164.03%-6.82M
148.93%710K
-7,273.17%-6.05M
-16.30%1.06M
-9.78%-2.55M
63.90%-2.58M
60.73%-1.45M
97.61%-82K
-Change in payables and accrued expense
-6,567.02%-12.53M
-63.70%-44.57M
24.84%-16.81M
1,964.17%19.87M
27.80%-9.26M
-101.30%-188K
-18.85%-27.23M
-151.31%-22.36M
-104.63%-1.07M
-189.82%-12.83M
-Change in other working capital
----
----
-1,028.44%-1.23M
4.34%-419K
-1,041.26%-1.35M
413.51%570K
-146.67%-35K
-108.50%-109K
-153.03%-438K
164.81%143K
Cash from discontinued investing activities
Operating cash flow
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
-39.39%-32.44M
Investing cash flow
Cash flow from continuing investing activities
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
-997.68%-69.54M
Net PPE purchase and sale
66.81%-155K
-46.88%-235K
-60.47%-2.17M
-5.32%-554K
-464.00%-987K
-91.39%-467K
60.59%-160K
43.35%-1.35M
52.53%-526K
52.05%-175K
Net investment purchase and sale
87.65%-2.29M
127.11%28.99M
-1.93%-129.33M
-135.91%-27.92M
134.75%24.11M
80.90%-18.57M
-180.96%-106.95M
-797.60%-126.89M
876.48%77.74M
-955.13%-69.37M
Cash from discontinued investing activities
Investing cash flow
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
-997.68%-69.54M
Financing cash flow
Cash flow from continuing financing activities
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
1,498.09%76.33M
Net issuance payments of debt
-100.68%-402K
---390K
-20.10%58.38M
---1.17M
--0
--59.55M
--0
-75.13%73.07M
--0
--73.07M
Net common stock issuance
-94.17%12K
--11K
80.00%342K
----
----
--206K
--0
-99.62%190K
----
----
Proceeds from stock option exercised by employees
-84.90%264K
-66.89%1.68M
-43.52%8.34M
-104.44%-178K
-47.96%1.69M
1,089.12%1.75M
-30.98%5.08M
-6.16%14.77M
15.07%4.01M
-31.89%3.25M
Net other financing activities
---1.84M
---2.35M
---34.58M
---2.17M
---262K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
1,498.09%76.33M
Net cash flow
Beginning cash position
-45.00%86.13M
-63.28%112.45M
-39.69%306.24M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
85.07%507.73M
21.80%248.34M
27.65%274.02M
Current changes in cash
31.91%-5.78M
82.63%-25.98M
3.91%-194.15M
-170.47%-40.56M
117.33%4.45M
93.21%-8.49M
-37.30%-149.54M
-186.60%-202.06M
-81.05%57.57M
-138.65%-25.66M
Effect of exchange rate changes
54.89%-143K
-254.17%-340K
-36.04%362K
57.70%522K
1,907.14%253K
-251.67%-317K
-340.00%-96K
697.18%566K
16,450.00%331K
12.50%-14K
End cash Position
-45.73%80.21M
-45.00%86.13M
-63.28%112.45M
-63.28%112.45M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
-39.69%306.24M
21.80%248.34M
Free cash flow
92.10%-1.52M
-13.10%-53.92M
40.37%-97.31M
61.14%-9.47M
35.98%-20.88M
31.14%-19.28M
39.04%-47.67M
-12.91%-163.2M
27.38%-24.38M
-37.98%-32.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M-39.39%-32.44M
Net income from continuing operations 83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M
Operating gains losses ----------29.02M--0--0--------------------
Depreciation and amortization -21.38%320K-24.44%306K15.17%1.66M6.82%423K7.97%420K21.49%407K27.76%405K84.94%1.44M131.58%396K69.87%389K
Other non cash items -17.36%19.6M-4.95%19.44M-13.65%86.23M-55.42%19.94M20.22%22.11M33.85%23.72M7.63%20.45M84.21%99.85M151.81%44.73M33.52%18.39M
Change In working capital -175.38%-18.3M-75.44%-48.52M45.03%-32.4M253.94%18.1M9.64%-16.2M-301.58%-6.64M15.04%-27.66M-825.57%-58.95M-179.66%-11.76M-311.17%-17.93M
-Change in receivables 8.25%-8.25M-290.14%-3.84M71.61%-6.1M61.14%-2.97M358.96%3.84M-69.73%-8.99M128.65%2.02M-3.14%-21.47M-136.04%-7.64M-206.23%-1.48M
-Change in inventory -17.71%739K-1,031.30%-1.22M88.33%-1.45M178.19%907K7.84%-3.39M112.41%898K137.01%131K-41.70%-12.42M45.72%-1.16M3.85%-3.67M
-Change in prepaid assets 64.16%1.75M143.42%1.11M-164.03%-6.82M148.93%710K-7,273.17%-6.05M-16.30%1.06M-9.78%-2.55M63.90%-2.58M60.73%-1.45M97.61%-82K
-Change in payables and accrued expense -6,567.02%-12.53M-63.70%-44.57M24.84%-16.81M1,964.17%19.87M27.80%-9.26M-101.30%-188K-18.85%-27.23M-151.31%-22.36M-104.63%-1.07M-189.82%-12.83M
-Change in other working capital ---------1,028.44%-1.23M4.34%-419K-1,041.26%-1.35M413.51%570K-146.67%-35K-108.50%-109K-153.03%-438K164.81%143K
Cash from discontinued investing activities
Operating cash flow 92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M-39.39%-32.44M
Investing cash flow
Cash flow from continuing investing activities 87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M-997.68%-69.54M
Net PPE purchase and sale 66.81%-155K-46.88%-235K-60.47%-2.17M-5.32%-554K-464.00%-987K-91.39%-467K60.59%-160K43.35%-1.35M52.53%-526K52.05%-175K
Net investment purchase and sale 87.65%-2.29M127.11%28.99M-1.93%-129.33M-135.91%-27.92M134.75%24.11M80.90%-18.57M-180.96%-106.95M-797.60%-126.89M876.48%77.74M-955.13%-69.37M
Cash from discontinued investing activities
Investing cash flow 87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M-997.68%-69.54M
Financing cash flow
Cash flow from continuing financing activities -106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M1,498.09%76.33M
Net issuance payments of debt -100.68%-402K---390K-20.10%58.38M---1.17M--0--59.55M--0-75.13%73.07M--0--73.07M
Net common stock issuance -94.17%12K--11K80.00%342K----------206K--0-99.62%190K--------
Proceeds from stock option exercised by employees -84.90%264K-66.89%1.68M-43.52%8.34M-104.44%-178K-47.96%1.69M1,089.12%1.75M-30.98%5.08M-6.16%14.77M15.07%4.01M-31.89%3.25M
Net other financing activities ---1.84M---2.35M---34.58M---2.17M---262K--------------------
Cash from discontinued financing activities
Financing cash flow -106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M1,498.09%76.33M
Net cash flow
Beginning cash position -45.00%86.13M-63.28%112.45M-39.69%306.24M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M85.07%507.73M21.80%248.34M27.65%274.02M
Current changes in cash 31.91%-5.78M82.63%-25.98M3.91%-194.15M-170.47%-40.56M117.33%4.45M93.21%-8.49M-37.30%-149.54M-186.60%-202.06M-81.05%57.57M-138.65%-25.66M
Effect of exchange rate changes 54.89%-143K-254.17%-340K-36.04%362K57.70%522K1,907.14%253K-251.67%-317K-340.00%-96K697.18%566K16,450.00%331K12.50%-14K
End cash Position -45.73%80.21M-45.00%86.13M-63.28%112.45M-63.28%112.45M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M-39.69%306.24M21.80%248.34M
Free cash flow 92.10%-1.52M-13.10%-53.92M40.37%-97.31M61.14%-9.47M35.98%-20.88M31.14%-19.28M39.04%-47.67M-12.91%-163.2M27.38%-24.38M-37.98%-32.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg